石巻市復興を考える市民の会　公式掲示板4 269219

mRNAワクチン接種と副作用リスト

1：市民の会 :
2022/03/28 (Mon) 08:21:53
host:*.openmobile.ne.jp: mRNAワクチン接種した場合、予想される「副作用」一覧

皆さんの「大好き」なmRNAワクチンを接種した場合に、皆さんの身体上に「発症」する可能性のある副作用一覧だ。

ーーーーーーーーーーーーーーーーーーーーーーーー
特別な注意を要する有害事象のリスト

1p36欠失症候群; 2-ヒドロキシグルタル酸尿症; 5 'ヌクレオチダーゼ増加; 音響神経炎;後天性C1阻害剤欠乏症;後天性表皮水疱症; 後天性表皮失語症;急性皮膚エリテマトーデス;急性散在性脳脊髄炎; 急性難治性の反復性部分発作を伴う脳炎;急性熱性好中球皮膚病;急性弛緩性脊髄炎;急性出血性白質脳炎; 急性乳児期の出血性浮腫;急性腎障害;急性黄斑網膜症; 急性運動性軸索ニューロパシー;急性運動感覚性軸索ニューロパシー; 急性心筋梗塞;急性呼吸窮迫症候群;急性呼吸不全; アジソン病疾患;投与部位血栓症;投与部位血管炎; 副腎血栓症;免疫化後の有害事象;味覚消失;無顆粒球症; 空気塞栓症;アラニンアミノトランスフェラーゼ異常;アラニンアミノトランスフェラーゼ増加;アルコール依存症発作; アレルギー性気管支肺真菌症;アレルギー性浮腫; 同種免疫肝炎;円形脱毛症;アルパース病;肺胞タンパク症;アンモニア異常; アンモニア増加;羊膜腔感染;アミロイド海馬切除術; アミロイド関節症;アミロイドーシス;老人性アミロイドーシス;アナフィラキシー反応; アナフィラキシーショック;アナフィラキシー輸血反応; アナフィラキシー反応;アナフィラキシーショック; 妊娠のアナフィラキシー様症候群;血管浮腫;血管障害性神経障害;強直性脊椎炎;無嗅覚症;抗アセチルコリン受容体抗体陽性;抗アクチン抗体陽性;抗アクアポリン-4抗体陽性;抗大脳基底核抗体陽性; 抗環状シトルリン化ペプチド抗体陽性;抗上皮抗体陽性;抗赤血球抗体陽性;抗エキソソーム複合体抗体陽性;抗GAD抗体陰性;抗GAD抗体陽性;抗ガングリオシド抗体陽性;抗グリアジン抗体陽性;抗糸球体基底膜抗体陽性;抗糸球体基底膜疾患; 抗グリシルtRNAシンテターゼ抗体陽性;抗HLA抗体検査陽性;抗IA2抗体陽性;抗インスリン抗体増加;抗インスリン抗体陽性;抗インスリン受容体抗体増加; 抗インスリン受容体抗体陽性;抗インターフェロン抗体陰性;抗インターフェロン抗体陽性;抗膵島細胞抗体陽性;抗ミトコンドリア抗体陽性;抗筋肉特定のキナーゼ抗体陽性;抗ミエリン関連糖タンパク質抗体陽性;抗ミエリン関連糖タンパク質関連多発性神経障害;抗心筋抗体陽性; 抗神経抗体陽性;抗好中球細胞質抗体増加;抗好中球細胞質抗体陽性;抗好中球細胞質抗体陽性血管炎;抗NMDA抗体陽性;抗核抗体増加;抗核抗体陽性;抗リン脂質抗体陽性;抗リン脂質抗体症候群;抗血小板抗体陽性;抗プロトロンビン抗体陽性;抗リボソームP抗体陽性;抗RNAポリメラーゼIII抗体陽性; Anti-saccharomycescerevisiae抗体検査陽性; Anti-sperm抗体陽性;抗SRP抗体陽性;抗シンテターゼ症候群;抗甲状腺抗体陽性;抗トランスグルタミナーゼ抗体増加;抗VGCC抗体陽性;抗VGKC抗体陽性;抗ビメンチン抗体陽性;抗ウイルス予防; 抗ウイルス治療;抗亜鉛トランスポーター8抗体陽性;大動脈塞栓;大動脈血栓症;大動脈炎;赤芽球癆;再生不良性貧血; 適用部位血栓症;適用部位血管炎;不整脈;動脈バイパス閉塞;動脈バイパス血栓症; 動静脈血栓症;動静脈瘻血栓症;動静脈グラフト部位狭窄;動静脈グラフト血栓症; 動脈炎;動脈炎冠状動脈;関節痛;関節炎;腸炎性関節炎;腹水;無菌海綿静脈洞血栓症; アスパラギン酸アミノトランスフェラーゼ異常;アスパラギン酸アミノトランスフェラーゼ増加; アスパラギン酸-グルタミン酸-トランスポーター欠乏症; AST対血小板比指数増加; AST / ALT比異常;喘息;無症候性COVID19; 運動失調;アテローム塞栓症;脱力発作;心房血栓症;萎縮性甲状腺炎; 非定型良性部分てんかん;非定型肺炎;オーラ;自己抗体陽性; 自己免疫貧血;自己免疫性再生不良性貧血;自己免疫性関節炎; 自己免疫性水疱疾患;自己免疫性胆管炎;自己免疫性大腸炎; 自己免疫性脱髄病気;自己免疫性皮膚炎;自己免疫疾患;自己免疫脳症;自己免疫内分泌障害;自己免疫腸症;自己免疫眼障害;自己免疫性溶血性貧血; 自己免疫性ヘパリン起因性血小板減少症;自己免疫性肝炎; 自己免疫性高脂血症;自己免疫性甲状腺機能低下症;自己免疫性内耳疾患;自己免疫性肺疾患; 自己免疫性リンパ増殖性症候群;自己免疫性心筋炎;自己免疫性筋炎; 自己免疫性腎炎;自己免疫性ニューロパチー;自己免疫性好中球減少症; 自己免疫性膵炎;自己免疫性汎血球減少症;自己免疫性心膜炎; 自己免疫性網膜症;自己免疫性甲状腺障害;自己免疫性甲状腺炎; 自己免疫性ブドウ膜炎;乳児腸炎を伴う自己炎症;自己炎症性疾患; 自動性てんかん;自律神経系の不均衡;自律神経発作; 軸性脊椎関節炎;腋窩静脈血栓症; 軸索および脱髄多発性神経障害;軸索神経障害;バクテリアサイト;バルト海ミオクローヌスてんかん; バンド感覚;バセドウ病;脳底動脈血栓症;好塩基球減少症; B細胞形成不全;ベーチェット症候群;良性の民族性好中球減少症; 良性の家族性新生児けいれん;良性家族性天疱瘡;良性ローランドてんかん; ベータ-2糖タンパク質抗体陽性;ビッカースタッフ脳炎;胆汁排出量異常; 胆汁排出量減少;胆汁腹水;ビリルビン抱合異常; ビリルビン抱合増加;ビリルビン尿あり;生検肝異常;ビオチニダーゼ欠損症; バードショット脈絡網膜症;血液アルカリホスファターゼ異常; 血液アルカリホスファターゼ増加;血中ビリルビン異常;血中ビリルビン増加; 血中ビリルビン非抱合型増加;血中コリンエステラーゼ異常;血中コリンエステラーゼ減少; 血圧減少;血圧拡張期が減少した;血圧収縮期減少;青いつま先症候群;腕頭静脈血栓症;脳幹塞栓症; 脳幹血栓症;ブロモスルフタレインテスト異常;気管支浮腫;気管支炎; 気管支炎マイコプラズマ;ウイルス性気管支炎;アレルギー性気管支肺アスペルギルス症;気管支痙攣; BuddChiari症候群;球麻痺;蝶発疹; C1q腎症;帝王切開;カルシウム塞栓症;毛細血管炎;カプラン症候群; 心アミロイドーシス;心停止; 心臓心不全;急性心不全;心臓サルコイドーシス;心室血栓症; 心原性ショック;カルジオリピン抗体陽性;心肺機能不全; 心肺機能低下;心臓呼吸困難;心臓血管不全; 頸動脈塞栓症;頸動脈血栓症;脱力発作;カテーテル部位血栓症; カテーテル部位血管炎;海綿静脈洞血栓症; CDKL5欠乏症; CEC症候群; セメント塞栓症;中枢神経系ループス;中枢神経系血管炎; 小脳動脈血栓症;小脳塞栓症;脳アミロイド血管症;脳動脈炎; 脳動脈塞栓症;脳静脈血栓症;脳ガス塞栓症; 脳微小塞栓症;脳静脈洞梗塞;脳血栓症; 脳静脈洞血栓症;脳静脈血栓症;脳脊髄液血栓症タンポナーデ;脳血管事故; 発作の症状の変化;胸の不快感; ChildPugh-Turcotteスコア異常; Child-Pugh-Turcotteスコア増加;しもやけ;窒息;窒息感;硬化性胆管炎;慢性自己免疫性糸球体腎炎;慢性皮膚エリテマトーデス;慢性疲労症候群;慢性胃炎;慢性炎症性脱髄多発根神経炎;橋動脈血管周囲を伴う慢性リンパ球性炎症ステロイドに反応する増強;慢性再発性多発性骨髄炎;慢性呼吸不全;慢性自発性蕁麻疹;循環虚脱;循環虚脱浮腫;周囲の腫れ;臨床的に孤立した症候群;間代性けいれん;セリアック病疾患;コーガン症候群;寒冷凝集素陽性;寒冷型溶血性貧血;大腸炎;びらん性大腸炎;ヘルペス性大腸炎;顕微鏡的大腸炎;潰瘍性大腸炎;コラーゲン障害;コラーゲン血管疾患;補体因子異常;補体因子C1 減少;補体因子C2減少;補体因子C3減少;補体因子C4が減少;補体因子減少; コンピューター断層撮影肝臓異常;同心性硬化症;先天性異常; 先天性両側性シルビウス周囲症候群;先天性単純ヘルペス感染症;先天性筋無力症候群; 先天性水痘感染症;うっ血性肝障害;小児期のけいれん;けいれん局所; けいれん性閾値の低下;クームス陽性溶血性貧血;冠状動脈疾患;冠状動脈塞栓症;冠状動脈血栓症;冠状動脈バイパス血栓症;コロナウイルス感染;コロナウイルス検査;コロナウイルス検査陰性;コロナウイルス検査陽性;脳梁離断術;咳;咳喘息; COVID-19; COVID-19 免疫化; COVID-19肺炎; COVID-19予防; COVID-19治療; 頭蓋神経障害;複数の脳神経麻痺;脳神経麻痺; CREST 症候群;クローン病;クリオグロブリン血症;クリオグロブリン血症; CSFオリゴクローナルバンド現在; CSWS症候群;皮膚アミロイドーシス;皮膚エリテマトーデス; 皮膚サルコイドーシス;皮膚血管炎;チアノーゼ;周期性好中球減少症;間質性膀胱炎;サイトカインリリース症候群;サイトカインストーム; 急性関連のdenovoプリン合成阻害剤炎症性症候群;新生児死亡;深部静脈血栓症;深部静脈血栓症術後;胆汁分泌の欠乏; Dejavu; 脱髄多発性神経障害;脱髄;皮膚炎;水疱性類天疱瘡;皮膚炎 herpetiformis;皮膚筋炎;デバイス塞栓術;デバイス関連血栓症;糖尿病真性糖尿病;糖尿病性ケトアシドーシス;糖尿病性肥満症;透析アミロイドーシス;透析膜反応;拡張期低血圧;びまん性血管炎;指孔瘢痕; 播種性血管内凝固症候群;新生児における播種性血管内凝固症候群;播種性血管内凝固症候群新生児単純ヘルペス;播種性水痘;播種性水痘帯状疱疹ワクチンウイルス感染症;播種性水痘帯状疱疹ウイルス感染症; DNA抗体陽性; 二重皮質症候群;二本鎖DNA抗体陽性;夢のような状態;ドレスラー症候群; ドロップ発作;薬物離脱けいれん;呼吸困難; 初期乳児てんかん性脳症バースト抑制;子癇;ヘルペス性湿疹;皮膚塞栓症;塞栓症小脳梗塞;塞栓性脳梗塞;塞栓性肺炎; 塞栓性脳卒中;塞栓症;動脈塞栓症;静脈塞栓症;脳炎;脳炎アレルギー;自己免疫性脳炎;脳幹脳炎; 脳炎出血性;脳炎periaxisisdiffusa; 脳炎ポスト免疫化;脳脊髄炎;脳症;内分泌障害; 内分泌眼症;気管内挿管;腸炎;白血球減少症;エンテロバクター肺炎; 腸炎;腸障害性脊椎炎;好酸球減少症;好酸球筋膜炎;多発性血管炎を伴う好酸球性肉芽腫症; 好酸球食道炎;表皮水疱症;てんかん;てんかん手術;ミオクローヌス-脱力発作を伴うてんかん発作;てんかん性前兆;てんかん性精神病;紅斑;バザン硬結性紅斑; 紅斑多形性;結節性紅斑;エヴァンス症候群;突発性発疹;拡張障害; ステータススケールスコア減少;拡張障害ステータススケールスコア増加;露出伝染病; SARS-CoV-2への曝露;眼の浮腫;眼の掻痒; 眼腫れ;眼瞼浮腫;顔面浮腫;顔面神経麻痺;顔面不全麻痺; 顔面上腕ジストニック発作;脂肪塞栓症;熱性けいれん;熱性感染症関連てんかん症候群;熱性好中球減少症;フェルティ症候群;大腿動脈塞栓症;線維性糸球体腎炎;線維筋痛症;紅潮;口の泡立ち;焦点皮質切除;焦点認知障害性発作;胎児機能不全症候群;胎児胎盤血栓症;胎児肝;異物塞栓症;前頭葉てんかん;劇症1型糖尿病糖尿病;ガラクトース排出能力試験異常;ガラクトース排出能力試験減少;ガンマ-グルタミルトランスフェラーゼ異常;ガンマ-グルタミルトランスフェラーゼ増加;胃炎ヘルペス;胃腸アミロイドーシス;笑い発作;全身性発症非運動性発作;全身性強直間代発作;性器ヘルペス;性器ヘルペスシンプレックス;性器帯状疱疹;巨細胞性動脈炎;糸球体腎炎;糸球体腎炎膜性増殖性糸球体腎炎膜性糸球体腎炎急速に糸球体腎炎進行性;舌咽神経麻痺;グルコーストランスポーター1型欠損症症候群;グルタミン酸デヒドロゲナーゼ増加;グリココール酸が増加した; GM2ガングリオシドーシス;グッドパスチャー症候群; 移植血栓症;肉芽細胞減少症;新生児肉芽細胞減少症;肉芽腫症多発血管炎;肉芽腫性皮膚炎;灰白質異所形成;グアナーゼ増加;ギラインバール症候群;溶血性貧血;血球貪食症リンパ組織球症;出血;出血性腹水;出血性障害;出血性肺炎;出血性水痘症候群; 出血性血管炎;ハンタウイルス肺感染症; 橋本病脳症;橋毒症;片側巨脳症;ヘノッホシェーンライン紫斑病;ヘノッホシェーンライン紫斑腎炎;ヘパプラスチン異常;ヘパプラスチン減少;ヘパリン起因性血小板減少症;肝アミロイドーシス;肝動脈塞栓症;肝動脈流減少;肝動脈血栓症;肝酵素異常;肝酵素減少;肝酵素の増加;肝線維症マーカーの異常;肝線維症マーカー増加;肝機能異常;肝水胸部; 肝肥大;肝低灌流;肝リンパ球浸潤;肝腫瘤;肝痛み;肝隔離;肝血管抵抗の増加;肝血管血栓症;肝静脈塞栓症;肝静脈血栓症;肝静脈圧勾配異常;肝静脈圧勾配増加;肝炎;肝胆道スキャン異常;肝腫大;肝脾腫; C1エステラーゼを伴う遺伝性血管浮腫阻害剤欠乏症;ヘルペス皮膚炎;ヘルペス妊娠性;ヘルペス食道炎;ヘルペス眼科; 単純ヘルペス咽頭炎;単純ヘルペス;単純ヘルペス;単純ヘルペス子宮頸管炎;単純ヘルペス大腸炎;単純ヘルペス脳炎;単純ヘルペス胃炎;ヘルペス単純ヘルペス肝炎;単純ヘルペス髄膜炎;単純ヘルペス髄膜脳炎;ヘルペス単純ヘルペス髄膜炎;単純ヘルペス壊死性網膜症;単純ヘルペス食道炎;単純ヘルペス外耳炎;単純ヘルペス咽頭炎;単純ヘルペス肺炎;単純ヘルペスの再活性化;単純ヘルペス敗血症;単純ヘルペスウイルス血症;単純ヘルペスウイルス結膜炎新生児;単純ヘルペス内臓;単純ヘルペスウイルス感染症;帯状疱疹;帯状疱疹皮膚播種;帯状疱疹感染症神経学的;帯状疱疹髄膜炎;帯状疱疹髄膜脳炎;帯状疱疹髄膜炎;帯状疱疹髄膜神経根炎;帯状疱疹壊死性網膜症;帯状疱疹耳鼻咽喉科;帯状疱疹咽頭炎;帯状疱疹再活性化;ヘルペス性神経根症;ヒストン抗体陽性;ホイグネ症候群; ヒトヘルペスウイルス6型脳炎;ヒトヘルペスウイルス6型感染症;ヒトヘルペスウイルス6型感染症再活性化;ヒトヘルペスウイルス7型感染症;ヒトヘルペスウイルス8型感染症;高アンモニア血症;高ビリルビン血症;高コリア;高ガンマグロブリン血症良性モノクローナル;高血糖発作;過敏症;過敏症血管炎;甲状腺機能亢進症;高経アミン血症;過呼吸;低アルブミン血症; H低カルシウム血症性発作;低ガンマグロブリン血症;舌下神経麻痺;舌下神経神経不全麻痺;低血糖発作;低血糖発作;低血圧;低血圧危機;小指球ハンマー症候群;甲状腺機能低下症;低酸素症;特発性CD4 リンパ球減少症;特発性全般てんかん;特発性間質性肺炎;特発性好中球減少症;特発性肺線維症; IgA腎症; IgM腎症;第3神経麻痺;第3神経不全麻痺;腸骨動脈塞栓症;免疫性血小板減少症;免疫性副作用;免疫性胆管炎;免疫性炎症性胆汁うっ滞; 免疫性炎症性細胞減少症;免疫性炎症性脳炎;免疫性炎症性疾患脳症;免疫性炎症性内分泌障害;免疫性炎症性腸炎;免疫性胃炎;免疫性肝障害;免疫性肝炎; 免疫性甲状腺機能亢進症;免疫性炎症性甲状腺機能低下症;免疫性炎症性疾患心筋炎;免疫性筋炎;免疫性腎炎;免疫性炎症性神経障害;免疫性炎症性膵炎;免疫性炎症性肺炎;免疫性炎症性疾患腎障害;免疫性炎症性甲状腺炎;免疫性ブドウ膜炎;免疫グロブリンG4 関連疾患;免疫グロブリン異常;インプラント部位血栓症;封入体筋炎;乳児の遺伝性無顆粒球症;乳児のけいれん;感染した血管炎;感染性血栓症;炎症;炎症性腸疾患;注入部位血栓症;注入部位血管炎;注射部位血栓症;注射部位蕁麻疹;注射部位血管炎;点滴注入部位血栓症;インスリン自己免疫症候群;間質性肉芽腫性皮膚炎;間質性肺疾患;心臓内腫瘤;心臓内血栓;頭蓋内圧力上昇;心内膜血栓症;内因子抗体異常;内因性因子抗体陽性; IPEX症候群;不規則な呼吸; IRVAN症候群; IVth神経麻痺; IVth神経不全麻痺; JCポリオーマウイルス検査陽性; JCウイルスCSF検査陽性; Jeavons症候群;頸静脈塞栓症;頸静脈血栓症;若年性特発性関節炎;若年性ミオクローヌスてんかん;若年性多発性筋炎;若年性乾癬関節炎;若年性脊椎関節炎;カポジ肉腫炎症性サイトカイン症候群;川崎病;カイザー・フライシャーリング;角化症;ケトシス傾向性糖尿病;コーニス症候群;ラフォラ病ミオクローヌスてんかん;ランブル病突出物;喉頭呼吸困難;喉頭浮腫;喉頭リウマチ関節炎;咽頭けいれん;喉頭気管浮腫;成人の潜在性自己免疫性糖尿病; LE 存在する細胞;レミエール症候群;レノックス・ガストー症候群;ロイシンアミノペプチダーゼ増加;白質脳脊髄炎;白質脳症;白血球減少;白血球減少新生児;ルイス-サムナー症候群;レルミット徴候;扁平苔癬;扁平苔癬;扁平苔癬硬化症;辺縁系脳炎;線状IgA病;唇浮腫;唇の腫れ;肝機能テスト異常;肝機能検査が減少;肝機能検査増加;肝硬結;肝障害;肝鉄濃度異常;肝鉄濃度増加;肝臓の混濁;肝臓の触知可能;肝臓のサルコイドーシス;肝臓のスキャン異常;低出生体重児;下気道ヘルペス感染症;下気道管感染症;下気道感染症ウイルス;肺膿瘍;ルポイド肝肝硬変;ループス膀胱炎;ループス脳炎;ループス心内膜炎;ループス腸炎;ループス肝炎;狼瘡心筋炎;狼瘡筋炎;狼瘡腎炎;狼瘡膵炎; 狼瘡胸膜炎;狼瘡性肺炎;狼瘡性血管炎;狼瘡様症候群;リンパ球性下垂体炎;リンパ球減少症新生児;リンパ球減少症; MAGIC症候群; 磁気肝臓の異常な画像診断;磁気共鳴陽子密度脂肪分画;マーラーサイン;マールブルグのバリアントマルチプル硬化症; マルキアファーヴァ-ビッグナミ病;マリンレンハート症候群;肥満細胞腸炎;妊娠中の母親の曝露;医療機器部位血栓症;医療デバイス部位血管炎; MELAS症候群;髄膜炎;無菌性髄膜炎;髄膜炎ヘルペス;単純ヘルペス新生児髄膜脳炎;髄膜脳炎ヘルペス;ヘルペス性髄膜炎; MERS-CoVテスト; MERS-CoVテスト陰性; MERS-CoVテスト陽性;腸間膜増殖性糸球体腎炎;腸間膜動脈塞栓症;腸間膜動脈血栓症;腸間膜静脈血栓症;メタニューモウイルス感染症;転移性皮膚クローン病;転移性肺塞栓症;細小血管障害;微小塞栓症;顕微鏡的多発血管炎;中東呼吸器症候群;片頭痛誘発性発作;粟粒性肺炎;フィッシャー症候群;ミトコンドリアアスパラギン酸アミノトランスフェラーゼの増加;混合性結合組織疾患;末期肝疾患スコア異常のモデル;末期肝疾患のモデルスコア増加;総分岐鎖アミノ酸とチロシンのモル比;モリブデン補因子欠乏症;単球減少症;単神経炎;単神経障害マルチプレックス;モルフォア;モルヴァン症候群;口の腫れ;もやもや病;多発性運動神経障害;多臓器不全症候群;多発性硬化症;多発性硬化症再発;多発性硬化症再発予防;複数の副鼻腔切除;小児の炎症性症候群;筋肉サルコイドーシス;重症筋無力症;重症筋無力症重症筋無力症;重症筋無力症新生児;筋無力症候群;脊髄炎;脊髄炎横方向;心筋梗塞;心筋炎;感染後の心筋炎;ミオクローヌスてんかん;ミオクローヌスてんかんとぼろぼろの赤い繊維;ミオキミア;筋炎;ナルコレプシー;鼻ヘルペス;鼻づまり;壊死性ヘルペス性網膜症;新生児クローン病;新生児てんかん発作;新生児エリテマトーデス;新生児粘膜皮膚ヘルペスシンプレックス;新生児肺炎;新生児けいれん;腎炎; 腎性全身性線維症;神経痛性筋萎縮症;神経炎;脳神経炎;視神経脊髄炎偽再発;視神経脊髄炎スペクトル障害;ニューロミオトニア; ニューロン神経障害;末梢神経障害;神経障害、運動失調、色素性網膜炎症候群;神経精神ループス;神経サルコイドーシス; 好中球減少症;好中球減少症新生児;好中球減少性大腸炎;好中球減少症感染症;好中球減少性敗血症;結節性発疹;結節性血管炎;非感染性脊髄炎;非感染性脳炎; 非感染性脳脊髄炎;非感染性卵巣炎;産科肺塞栓症;職業性伝染病への曝露; SARS-CoV-2への職業的曝露; 眼球充血;眼筋無力症;眼類天疱瘡;眼サルコイドーシス;眼血管炎;眼顔面麻痺;浮腫;水疱浮腫;肝浮腫病気;浮腫口;食道アカラシア;眼動脈血栓症;眼単純ヘルペス;眼部帯状疱疹;眼静脈血栓症;視神経炎;視神経神経障害;視神経周囲炎;口腔ヘルペス;口腔扁平苔癬;中咽頭浮腫;中咽頭けいれん;中咽頭の腫れ;浸透圧性脱髄症候群;卵巣静脈血栓症;重複症候群; 小児自己免疫連鎖球菌感染症に関連する神経精神障害; Paget-Schroetter 症候群;回文性リウマチ;パリセーズ好中球性肉芽腫皮膚炎;掌蹠角化症;触知可能紫斑;膵炎;膵炎;乳頭静脈炎;傍癌性肺炎;パラドキシカル塞栓症;パラインフルエンザウイルス性喉頭気管気管支炎; 腫瘍随伴皮膚筋炎;腫瘍随伴性天疱瘡;腫瘍随伴性血栓症; 頭蓋不全麻痺神経;壁細胞抗体陽性;発作性夜間ヘモグロビン尿症; 部分的発作;二次一般化を伴う部分発作;骨盤静脈血栓症;類天疱瘡;天疱瘡;陰茎静脈血栓症;心膜炎;心膜炎狼瘡;眼窩周囲の不快感;眼窩周囲の浮腫;眼窩周囲の腫れ; 末梢動脈血栓症;末梢塞栓症;末梢虚血;末梢静脈血栓伸展;門脈周囲浮腫;腹腔液タンパク質異常;腹腔液タンパク質減少;腹膜液タンパク質の増加;狼瘡性腹膜炎;悪性貧血; プチマルてんかん;咽頭浮腫;咽頭腫脹; Pityriasis lichenoides et varioliformis acuta;前置胎盤; Pleuroparenchymalfibroelastosis; Pneumobilia; Pneumonia; Pneumonia アデノウイルス;肺炎サイトメガロウイルス;肺炎ヘルペスウイルス;肺炎インフルエンザ;肺炎はしか;肺炎マイコプラズマ;肺炎壊死;肺炎パラインフルエンザウイルス;肺炎呼吸器合胞体ウイルス;肺炎ウイルス; POEMS症候群;結節性多発動脈炎;多発性関節炎;多発性軟骨炎;多発性自己免疫症候群I型;多腺性自己免疫症候群II型; 多腺性自己免疫症候群III型;多腺障害;多小脳回;多小脳回リウマチ性多発性筋炎; 多発性神経障害;多発性神経障害特発性進行性;門脈膿血症;門脈塞栓症;門脈流減少;門脈圧増加;門脈血栓症;門脈脾腸腸静脈血栓症;術後低血圧;術後肺炎;術後肺塞栓症;脳卒中後てんかん;脳卒中後発作;血栓性網膜症後;血栓性症候群後;ウイルス後疲労症候群;発作後頭痛;発作後麻痺;発作後精神病;発作後状態;術後呼吸窮迫;術後呼吸不全;術後血栓症;産後血栓症;産後静脈血栓症;心膜切開後症候群;外傷後てんかん;体位性頻脈症候群;大脳前動脈血栓症;子癇前症;発作前の状態;早産;早産閉経;原発性アミロイドーシス;原発性胆汁性胆管炎;原発性進行性多発性硬化症;処置ショック;直腸炎ヘルペス;直腸炎潰瘍性; 半球萎縮症;進行性多巣性白質脳症;進行性多巣性硬化症;進行性再発性多発性硬化症;人工心臓弁血栓症;そう痒症;そう痒症アレルギー;偽血管炎;乾癬;乾癬関節症;肺アミロイドーシス;肺動脈血栓症;肺塞栓症;肺線維症;肺出血;肺微小塞栓;肺油性微小塞栓症;肺腎症候群;肺サルコイドーシス;肺敗血症;肺血栓症;肺腫瘍血栓性微小血管症;肺血管炎;肺静脈閉塞症;肺静脈血栓症;膿皮症ガングレノサム;壊疽性膿疱症;発熱;検疫;放射線白血球減少症;神経根炎腕神経叢;放射線学的に孤立した症候群;発疹;紅斑性発疹;掻痒性発疹;ラスムッセン脳炎;レイノー現象;反応性毛細血管内皮増殖;再発多発性硬化症;再発寛解型多発性硬化症;腎アミロイドーシス;腎動脈炎;腎動脈血栓症;腎塞栓症;腎不全;腎血管血栓症;腎血管炎;腎静脈塞栓症;腎静脈血栓症;呼吸器逮捕;呼吸器疾患;呼吸困難;呼吸不全;呼吸器麻痺;呼吸器合胞体ウイルス細気管支炎;呼吸器合胞体ウイルス気管支炎;網膜動脈塞栓症;網膜動脈閉塞症;網膜動脈血栓症;網膜血管血栓症;網膜血管炎;網膜静脈閉塞症;網膜静脈血栓症;レチノール結合タンパク質の減少;網膜症;逆行性門脈流;後腹膜線維症;可逆性気道閉塞;レイノルド症候群;リウマチ性脳疾患;リウマチ性障害;リウマチ性関節炎;リウマチ因子の増加;リウマチ性因子陽性;リウマチ因子の量的増加;リウマチ肺;リウマチ好中球性皮膚症;リウマチ結節;リウマチ結節の除去;リウマチ強膜炎;関節リウマチ;衝動性眼球運動; SAPHO 症候群;サルコイドーシス; SARS-CoV-1テスト; SARS-CoV-1テスト陰性; SARS-CoV-1テスト陽性; SARS-CoV-2抗体検査; SARS-CoV-2抗体検査陰性; SARS-CoV-2 抗体検査陽性; SARS-CoV-2キャリア; SARS-CoV-2敗血症; SARS-CoV-2検査; SARSCoV-2検査偽陰性; SARS-CoV-2検査偽陽性; SARS-CoV-2検査陰性; SARSCoV -2テスト陽性; SARS-CoV-2ウイルス血症;里吉症候群;統合失調症;強膜炎;手指硬化症;強皮症;強皮症関連手指潰瘍;強皮症腎危機;強皮症様反応;二次性アミロイドーシス;二次性小脳変性;二次性進行型多発性硬化症;セグメント化されたhyalinising血管炎;発作;発作無酸素症;発作クラスター;発作現象のような;発作の予防;異物の感覚;敗血症の塞栓;敗血症肺塞栓症;重症急性呼吸器症候群;重症ミオクローヌスてんかん乳児期;ショック;ショック症状;収縮性肺症候群;シャント血栓症;サイレント甲状腺炎;単純な部分発作;シェーグレン症候群;皮膚の腫れ; SLE関節炎;滑らか筋抗体陽性;くしゃみ;脊髄動脈塞栓症;脊髄動脈血栓症;脾動脈動脈血栓症;脾臓塞栓症;脾臓血栓症;脾静脈血栓症;脊椎炎;脊椎関節症;自発的ヘパリン起因性ヘパリン起因性血小板減少症症候群;てんかん重積状態;スティーブンス・ジョンソン症候群;下肢の硬直症候群;スティッフパーソン症候群; 死産;死産;ストーマ部位血栓症;ストーマ部位血管炎;ストレス性心筋症;喘鳴;亜急性皮膚エリテマトーデス; 亜急性心内膜炎;亜急性炎症性脱髄性多発神経障害;鎖骨下動脈塞栓症;鎖骨下動脈血栓症; 鎖骨下静脈血栓症;突然の原因不明てんかんでの死亡; 上矢状静脈洞血栓症;スザック症候群; COVID19の疑い;腫れ;顔の腫れ; 眼瞼の腫れ;舌の腫れ;交感神経眼炎;全身性エリテマトーデス; 全身性エリテマトーデス疾患活動性指数異常;全身性エリテマトーデス疾患活動性指数の低下; 全身性エリテマトーデス疾患活動性指数が増加した;全身性エリテマトーデス発疹;全身性強皮症;全身性硬化症肺;頻脈;頻呼吸;高安動脈炎;側頭葉てんかん;末端回腸炎;精巣の自己免疫;喉の圧迫感;血栓性血管炎 obliterans;血小板減少症;血小板減少症紫斑;血栓性静脈炎;血栓性静脈炎ミグラン;血栓性静脈炎新生児;トロンボプラスチン敗血症;トロンボプラスチン表在性;トロンボプラスチン抗体陽性;血栓症;海綿体血栓症;デバイス内の血栓症;血栓症腸間膜血管;血栓性脳梗塞;血栓性微小血管症;血栓性脳卒中;血栓性血小板減少性紫斑病;甲状腺障害;甲状腺刺激ホルモン免疫グロブリンの増加;甲状腺炎;舌アミロイドーシス;舌噛みつき; 舌浮腫;強直間代運動;緊張性けいれん;緊張性姿勢;上部切除; 総胆汁酸の増加;中毒性表皮壊死症;白質脳症;有毒油症候群;気管閉塞;気管浮腫;気管気管支炎;気管気管支炎マイコプラズマ;ウイルス性気管気管支炎;異常なトランスアミナーゼ;トランスアミナーゼ増加;輸血関連の同種免疫性好中球減少症;一過性てんかん健忘症;横静脈洞血栓症;三叉神経不全麻痺;三叉神経神経痛;三叉神経痛; Truncuscoeliacus血栓症;結節性硬化症複雑;尿細管間質性腎炎およびブドウ膜炎症候群; 腫瘤形成性多発性硬化症;腫瘍塞栓症;腫瘍血栓症; 1型糖尿病; I型過敏症; III型免疫複合体を介した反応;ウートフ徴候現象;潰瘍性角膜炎;超音波肝臓異常;臍帯血栓症;鉤状束;未分化結合組織疾患;上気道閉塞;尿ビリルビン増加;ウロビリノーゲン尿減少;ウロビリノーゲン尿増加; 蕁麻疹;丘疹性蕁麻疹;蕁麻疹性血管炎;子宮破裂;ブドウ膜炎;ワクチン接種部位血栓症;ワクチン接種部位血管炎; 迷走神経麻痺;水痘;水痘角膜炎;水痘後ワクチン;水痘帯状疱疹胃炎;水痘帯状疱疹食道炎;水痘帯状疱疹肺炎;水痘帯状疱疹敗血症;水痘帯状疱疹ウイルス感染症;前置血管;血管グラフト血栓症; 血管仮性動脈瘤血栓症;血管性紫斑病;血管性ステント血栓症;血管炎性発疹; 血管炎性潰瘍;血管炎;胃腸血管炎;壊死性血管炎;大静脈塞栓症;大静脈血栓症;静脈血管内侵入;静脈再開通;静脈血栓症;妊娠中の静脈血栓症;静脈血栓症の四肢;静脈血栓症新生児;椎骨動脈血栓症;血管穿刺部位血栓症;内臓静脈血栓症; VIth神経麻痺; VIth神経不全麻痺;白斑;声帯麻痺;声帯不全麻痺;原田病;温型溶血性貧血;喘鳴;白乳頭徴候;第11神経麻痺; X線肝胆道異常;ヤング症候群;ジカウイルス関連するギランバレー症候群

ーーーーーーーーーーーーー
（引用元　https://go2senkyo.com/seijika/181630/posts/373694　）

https://qootan-4.bbs.fc2.com/?act=reply&tid=16716754
2：市民の会 :
2022/03/28 (Mon) 08:24:31
host:*.openmobile.ne.jp: これを「ワクチン」だと思いこむ人は（このリストを見ても）馬と鹿の区別ができない人ですよ（救いようがない人だ）。

こんなものを、よくもまあ大切な我が子、孫に注射したものだ。今すぐ、親をやめろ。
3：市民の会 :
2022/03/28 (Mon) 11:15:56
host:*.openmobile.ne.jp: 2回も接種したんですもの。

毒を食らわば皿まで、というじゃありませんか。3回、4回、5回と接種して元気になりましょう。
4：市民の会 :
2022/03/28 (Mon) 17:19:51
host:*.openmobile.ne.jp: https://twitter.com/goooodthai/status/1380130805561896962

凄いもんですな。

製薬会社から「金」を貰った以上、製薬会社に忖度するのは自然な成り行き。

ーーーーーーーーーーーーー
このような腐った人間にだけは、なりたくないものですよ。
5：市民の会 :
2022/03/28 (Mon) 20:01:17
host:*.openmobile.ne.jp: “ワクチン後遺症” 看護師が接種後の深刻な体調不良に悩む。２４時間点滴…難病が再燃。体調不良と戦いながら女性はある活動も開始【大石が聞く】
6：市民の会 :
2022/03/28 (Mon) 20:04:16
host:*.openmobile.ne.jp: ワクチン接種後に血小板減少性紫斑病が再燃。体調不良で休職を余儀なくされた実態は？【大石が深掘り解説】 (22/03/24 21:30)
7：市民の会 :
2022/03/30 (Wed) 13:49:15
host:*.openmobile.ne.jp: https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 1
APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
1p36 deletion syndrome;2-Hydroxyglutaric aciduria;5'nucleotidase increased;Acoustic
neuritis;Acquired C1 inhibitor deficiency;Acquired epidermolysis bullosa;Acquired epileptic
aphasia;Acute cutaneous lupus erythematosus;Acute disseminated encephalomyelitis;Acute
encephalitis with refractory, repetitive partial seizures;Acute febrile neutrophilic
dermatosis;Acute flaccid myelitis;Acute haemorrhagic leukoencephalitis;Acute
haemorrhagic oedema of infancy;Acute kidney injury;Acute macular outer retinopathy;Acute
motor axonal neuropathy;Acute motor-sensory axonal neuropathy;Acute myocardial
infarction;Acute respiratory distress syndrome;Acute respiratory failure;Addison's
disease;Administration site thrombosis;Administration site vasculitis;Adrenal
thrombosis;Adverse event following immunisation;Ageusia;Agranulocytosis;Air
embolism;Alanine aminotransferase abnormal;Alanine aminotransferase increased;Alcoholic
seizure;Allergic bronchopulmonary mycosis;Allergic oedema;Alloimmune
hepatitis;Alopecia areata;Alpers disease;Alveolar proteinosis;Ammonia abnormal;Ammonia
increased;Amniotic cavity infection;Amygdalohippocampectomy;Amyloid
arthropathy;Amyloidosis;Amyloidosis senile;Anaphylactic reaction;Anaphylactic
shock;Anaphylactic transfusion reaction;Anaphylactoid reaction;Anaphylactoid
shock;Anaphylactoid syndrome of pregnancy;Angioedema;Angiopathic
neuropathy;Ankylosing spondylitis;Anosmia;Antiacetylcholine receptor antibody
positive;Anti-actin antibody positive;Anti-aquaporin-4 antibody positive;Anti-basal ganglia
antibody positive;Anti-cyclic citrullinated peptide antibody positive;Anti-epithelial antibody
positive;Anti-erythrocyte antibody positive;Anti-exosome complex antibody positive;AntiGAD antibody negative;Anti-GAD antibody positive;Anti-ganglioside antibody
positive;Antigliadin antibody positive;Anti-glomerular basement membrane antibody
positive;Anti-glomerular basement membrane disease;Anti-glycyl-tRNA synthetase antibody
positive;Anti-HLA antibody test positive;Anti-IA2 antibody positive;Anti-insulin antibody
increased;Anti-insulin antibody positive;Anti-insulin receptor antibody increased;Antiinsulin receptor antibody positive;Anti-interferon antibody negative;Anti-interferon antibody
positive;Anti-islet cell antibody positive;Antimitochondrial antibody positive;Anti-muscle
specific kinase antibody positive;Anti-myelin-associated glycoprotein antibodies
positive;Anti-myelin-associated glycoprotein associated polyneuropathy;Antimyocardial
antibody positive;Anti-neuronal antibody positive;Antineutrophil cytoplasmic antibody
increased;Antineutrophil cytoplasmic antibody positive;Anti-neutrophil cytoplasmic
antibody positive vasculitis;Anti-NMDA antibody positive;Antinuclear antibody
increased;Antinuclear antibody positive;Antiphospholipid antibodies
positive;Antiphospholipid syndrome;Anti-platelet antibody positive;Anti-prothrombin
antibody positive;Antiribosomal P antibody positive;Anti-RNA polymerase III antibody
positive;Anti-saccharomyces cerevisiae antibody test positive;Anti-sperm antibody
positive;Anti-SRP antibody positive;Antisynthetase syndrome;Anti-thyroid antibody
positive;Anti-transglutaminase antibody increased;Anti-VGCC antibody positive;AntiVGKC antibody positive;Anti-vimentin antibody positive;Antiviral prophylaxis;Antiviral
treatment;Anti-zinc transporter 8 antibody positive;Aortic embolus;Aortic
thrombosis;Aortitis;Aplasia pure red cell;Aplastic anaemia;Application site
thrombosis;Application site vasculitis;Arrhythmia;Arterial bypass occlusion;Arterial bypass
thrombosis;Arterial thrombosis;Arteriovenous fistula thrombosis;Arteriovenous graft site
stenosis;Arteriovenous graft thrombosis;Arteritis;Arteritis

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 2
coronary;Arthralgia;Arthritis;Arthritis enteropathic;Ascites;Aseptic cavernous sinus
thrombosis;Aspartate aminotransferase abnormal;Aspartate aminotransferase
increased;Aspartate-glutamate-transporter deficiency;AST to platelet ratio index
increased;AST/ALT ratio abnormal;Asthma;Asymptomatic COVID19;Ataxia;Atheroembolism;Atonic seizures;Atrial thrombosis;Atrophic thyroiditis;Atypical
benign partial epilepsy;Atypical pneumonia;Aura;Autoantibody positive;Autoimmune
anaemia;Autoimmune aplastic anaemia;Autoimmune arthritis;Autoimmune blistering
disease;Autoimmune cholangitis;Autoimmune colitis;Autoimmune demyelinating
disease;Autoimmune dermatitis;Autoimmune disorder;Autoimmune
encephalopathy;Autoimmune endocrine disorder;Autoimmune enteropathy;Autoimmune eye
disorder;Autoimmune haemolytic anaemia;Autoimmune heparin-induced
thrombocytopenia;Autoimmune hepatitis;Autoimmune hyperlipidaemia;Autoimmune
hypothyroidism;Autoimmune inner ear disease;Autoimmune lung disease;Autoimmune
lymphoproliferative syndrome;Autoimmune myocarditis;Autoimmune myositis;Autoimmune
nephritis;Autoimmune neuropathy;Autoimmune neutropenia;Autoimmune
pancreatitis;Autoimmune pancytopenia;Autoimmune pericarditis;Autoimmune
retinopathy;Autoimmune thyroid disorder;Autoimmune thyroiditis;Autoimmune
uveitis;Autoinflammation with infantile enterocolitis;Autoinflammatory disease;Automatism
epileptic;Autonomic nervous system imbalance;Autonomic seizure;Axial
spondyloarthritis;Axillary vein thrombosis;Axonal and demyelinating
polyneuropathy;Axonal neuropathy;Bacterascites;Baltic myoclonic epilepsy;Band
sensation;Basedow's disease;Basilar artery thrombosis;Basophilopenia;B-cell
aplasia;Behcet's syndrome;Benign ethnic neutropenia;Benign familial neonatal
convulsions;Benign familial pemphigus;Benign rolandic epilepsy;Beta-2 glycoprotein
antibody positive;Bickerstaff's encephalitis;Bile output abnormal;Bile output
decreased;Biliary ascites;Bilirubin conjugated abnormal;Bilirubin conjugated
increased;Bilirubin urine present;Biopsy liver abnormal;Biotinidase deficiency;Birdshot
chorioretinopathy;Blood alkaline phosphatase abnormal;Blood alkaline phosphatase
increased;Blood bilirubin abnormal;Blood bilirubin increased;Blood bilirubin unconjugated
increased;Blood cholinesterase abnormal;Blood cholinesterase decreased;Blood pressure
decreased;Blood pressure diastolic decreased;Blood pressure systolic decreased;Blue toe
syndrome;Brachiocephalic vein thrombosis;Brain stem embolism;Brain stem
thrombosis;Bromosulphthalein test abnormal;Bronchial oedema;Bronchitis;Bronchitis
mycoplasmal;Bronchitis viral;Bronchopulmonary aspergillosis allergic;Bronchospasm;BuddChiari syndrome;Bulbar palsy;Butterfly rash;C1q nephropathy;Caesarean section;Calcium
embolism;Capillaritis;Caplan's syndrome;Cardiac amyloidosis;Cardiac arrest;Cardiac
failure;Cardiac failure acute;Cardiac sarcoidosis;Cardiac ventricular thrombosis;Cardiogenic
shock;Cardiolipin antibody positive;Cardiopulmonary failure;Cardio-respiratory
arrest;Cardio-respiratory distress;Cardiovascular insufficiency;Carotid arterial
embolus;Carotid artery thrombosis;Cataplexy;Catheter site thrombosis;Catheter site
vasculitis;Cavernous sinus thrombosis;CDKL5 deficiency disorder;CEC syndrome;Cement
embolism;Central nervous system lupus;Central nervous system vasculitis;Cerebellar artery
thrombosis;Cerebellar embolism;Cerebral amyloid angiopathy;Cerebral arteritis;Cerebral
artery embolism;Cerebral artery thrombosis;Cerebral gas embolism;Cerebral
microembolism;Cerebral septic infarct;Cerebral thrombosis;Cerebral venous sinus
thrombosis;Cerebral venous thrombosis;Cerebrospinal thrombotic

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 3
tamponade;Cerebrovascular accident;Change in seizure presentation;Chest discomfort;ChildPugh-Turcotte score abnormal;Child-Pugh-Turcotte score
increased;Chillblains;Choking;Choking sensation;Cholangitis sclerosing;Chronic
autoimmune glomerulonephritis;Chronic cutaneous lupus erythematosus;Chronic fatigue
syndrome;Chronic gastritis;Chronic inflammatory demyelinating
polyradiculoneuropathy;Chronic lymphocytic inflammation with pontine perivascular
enhancement responsive to steroids;Chronic recurrent multifocal osteomyelitis;Chronic
respiratory failure;Chronic spontaneous urticaria;Circulatory collapse;Circumoral
oedema;Circumoral swelling;Clinically isolated syndrome;Clonic convulsion;Coeliac
disease;Cogan's syndrome;Cold agglutinins positive;Cold type haemolytic
anaemia;Colitis;Colitis erosive;Colitis herpes;Colitis microscopic;Colitis ulcerative;Collagen
disorder;Collagen-vascular disease;Complement factor abnormal;Complement factor C1
decreased;Complement factor C2 decreased;Complement factor C3 decreased;Complement
factor C4 decreased;Complement factor decreased;Computerised tomogram liver
abnormal;Concentric sclerosis;Congenital anomaly;Congenital bilateral perisylvian
syndrome;Congenital herpes simplex infection;Congenital myasthenic syndrome;Congenital
varicella infection;Congestive hepatopathy;Convulsion in childhood;Convulsions
local;Convulsive threshold lowered;Coombs positive haemolytic anaemia;Coronary artery
disease;Coronary artery embolism;Coronary artery thrombosis;Coronary bypass
thrombosis;Coronavirus infection;Coronavirus test;Coronavirus test negative;Coronavirus
test positive;Corpus callosotomy;Cough;Cough variant asthma;COVID-19;COVID-19
immunisation;COVID-19 pneumonia;COVID-19 prophylaxis;COVID-19 treatment;Cranial
nerve disorder;Cranial nerve palsies multiple;Cranial nerve paralysis;CREST
syndrome;Crohn's disease;Cryofibrinogenaemia;Cryoglobulinaemia;CSF oligoclonal band
present;CSWS syndrome;Cutaneous amyloidosis;Cutaneous lupus erythematosus;Cutaneous
sarcoidosis;Cutaneous vasculitis;Cyanosis;Cyclic neutropenia;Cystitis interstitial;Cytokine
release syndrome;Cytokine storm;De novo purine synthesis inhibitors associated acute
inflammatory syndrome;Death neonatal;Deep vein thrombosis;Deep vein thrombosis
postoperative;Deficiency of bile secretion;Deja vu;Demyelinating
polyneuropathy;Demyelination;Dermatitis;Dermatitis bullous;Dermatitis
herpetiformis;Dermatomyositis;Device embolisation;Device related thrombosis;Diabetes
mellitus;Diabetic ketoacidosis;Diabetic mastopathy;Dialysis amyloidosis;Dialysis membrane
reaction;Diastolic hypotension;Diffuse vasculitis;Digital pitting scar;Disseminated
intravascular coagulation;Disseminated intravascular coagulation in newborn;Disseminated
neonatal herpes simplex;Disseminated varicella;Disseminated varicella zoster vaccine virus
infection;Disseminated varicella zoster virus infection;DNA antibody positive;Double cortex
syndrome;Double stranded DNA antibody positive;Dreamy state;Dressler's syndrome;Drop
attacks;Drug withdrawal convulsions;Dyspnoea;Early infantile epileptic encephalopathy with
burst-suppression;Eclampsia;Eczema herpeticum;Embolia cutis medicamentosa;Embolic
cerebellar infarction;Embolic cerebral infarction;Embolic pneumonia;Embolic
stroke;Embolism;Embolism arterial;Embolism venous;Encephalitis;Encephalitis
allergic;Encephalitis autoimmune;Encephalitis brain stem;Encephalitis
haemorrhagic;Encephalitis periaxialis diffusa;Encephalitis post
immunisation;Encephalomyelitis;Encephalopathy;Endocrine disorder;Endocrine
ophthalmopathy;Endotracheal intubation;Enteritis;Enteritis leukopenic;Enterobacter
pneumonia;Enterocolitis;Enteropathic spondylitis;Eosinopenia;Eosinophilic

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 4
fasciitis;Eosinophilic granulomatosis with polyangiitis;Eosinophilic
oesophagitis;Epidermolysis;Epilepsy;Epilepsy surgery;Epilepsy with myoclonic-atonic
seizures;Epileptic aura;Epileptic psychosis;Erythema;Erythema induratum;Erythema
multiforme;Erythema nodosum;Evans syndrome;Exanthema subitum;Expanded disability
status scale score decreased;Expanded disability status scale score increased;Exposure to
communicable disease;Exposure to SARS-CoV-2;Eye oedema;Eye pruritus;Eye
swelling;Eyelid oedema;Face oedema;Facial paralysis;Facial paresis;Faciobrachial dystonic
seizure;Fat embolism;Febrile convulsion;Febrile infection-related epilepsy syndrome;Febrile
neutropenia;Felty's syndrome;Femoral artery embolism;Fibrillary
glomerulonephritis;Fibromyalgia;Flushing;Foaming at mouth;Focal cortical resection;Focal
dyscognitive seizures;Foetal distress syndrome;Foetal placental thrombosis;Foetor
hepaticus;Foreign body embolism;Frontal lobe epilepsy;Fulminant type 1 diabetes
mellitus;Galactose elimination capacity test abnormal;Galactose elimination capacity test
decreased;Gamma-glutamyltransferase abnormal;Gamma-glutamyltransferase
increased;Gastritis herpes;Gastrointestinal amyloidosis;Gelastic seizure;Generalised onset
non-motor seizure;Generalised tonic-clonic seizure;Genital herpes;Genital herpes
simplex;Genital herpes zoster;Giant cell arteritis;Glomerulonephritis;Glomerulonephritis
membranoproliferative;Glomerulonephritis membranous;Glomerulonephritis rapidly
progressive;Glossopharyngeal nerve paralysis;Glucose transporter type 1 deficiency
syndrome;Glutamate dehydrogenase increased;Glycocholic acid increased;GM2
gangliosidosis;Goodpasture's syndrome;Graft
thrombosis;Granulocytopenia;Granulocytopenia neonatal;Granulomatosis with
polyangiitis;Granulomatous dermatitis;Grey matter heterotopia;Guanase increased;GuillainBarre syndrome;Haemolytic anaemia;Haemophagocytic
lymphohistiocytosis;Haemorrhage;Haemorrhagic ascites;Haemorrhagic
disorder;Haemorrhagic pneumonia;Haemorrhagic varicella syndrome;Haemorrhagic
vasculitis;Hantavirus pulmonary infection;Hashimoto's
encephalopathy;Hashitoxicosis;Hemimegalencephaly;Henoch-Schonlein purpura;HenochSchonlein purpura nephritis;Hepaplastin abnormal;Hepaplastin decreased;Heparin-induced
thrombocytopenia;Hepatic amyloidosis;Hepatic artery embolism;Hepatic artery flow
decreased;Hepatic artery thrombosis;Hepatic enzyme abnormal;Hepatic enzyme
decreased;Hepatic enzyme increased;Hepatic fibrosis marker abnormal;Hepatic fibrosis
marker increased;Hepatic function abnormal;Hepatic hydrothorax;Hepatic
hypertrophy;Hepatic hypoperfusion;Hepatic lymphocytic infiltration;Hepatic mass;Hepatic
pain;Hepatic sequestration;Hepatic vascular resistance increased;Hepatic vascular
thrombosis;Hepatic vein embolism;Hepatic vein thrombosis;Hepatic venous pressure
gradient abnormal;Hepatic venous pressure gradient increased;Hepatitis;Hepatobiliary scan
abnormal;Hepatomegaly;Hepatosplenomegaly;Hereditary angioedema with C1 esterase
inhibitor deficiency;Herpes dermatitis;Herpes gestationis;Herpes oesophagitis;Herpes
ophthalmic;Herpes pharyngitis;Herpes sepsis;Herpes simplex;Herpes simplex
cervicitis;Herpes simplex colitis;Herpes simplex encephalitis;Herpes simplex gastritis;Herpes
simplex hepatitis;Herpes simplex meningitis;Herpes simplex meningoencephalitis;Herpes
simplex meningomyelitis;Herpes simplex necrotising retinopathy;Herpes simplex
oesophagitis;Herpes simplex otitis externa;Herpes simplex pharyngitis;Herpes simplex
pneumonia;Herpes simplex reactivation;Herpes simplex sepsis;Herpes simplex
viraemia;Herpes simplex virus conjunctivitis neonatal;Herpes simplex visceral;Herpes virus

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 5
infection;Herpes zoster;Herpes zoster cutaneous disseminated;Herpes zoster infection
neurological;Herpes zoster meningitis;Herpes zoster meningoencephalitis;Herpes zoster
meningomyelitis;Herpes zoster meningoradiculitis;Herpes zoster necrotising
retinopathy;Herpes zoster oticus;Herpes zoster pharyngitis;Herpes zoster
reactivation;Herpetic radiculopathy;Histone antibody positive;Hoigne's syndrome;Human
herpesvirus 6 encephalitis;Human herpesvirus 6 infection;Human herpesvirus 6 infection
reactivation;Human herpesvirus 7 infection;Human herpesvirus 8
infection;Hyperammonaemia;Hyperbilirubinaemia;Hypercholia;Hypergammaglobulinaemia
benign monoclonal;Hyperglycaemic seizure;Hypersensitivity;Hypersensitivity
vasculitis;Hyperthyroidism;Hypertransaminasaemia;Hyperventilation;Hypoalbuminaemia;H
ypocalcaemic seizure;Hypogammaglobulinaemia;Hypoglossal nerve paralysis;Hypoglossal
nerve paresis;Hypoglycaemic seizure;Hyponatraemic seizure;Hypotension;Hypotensive
crisis;Hypothenar hammer syndrome;Hypothyroidism;Hypoxia;Idiopathic CD4
lymphocytopenia;Idiopathic generalised epilepsy;Idiopathic interstitial pneumonia;Idiopathic
neutropenia;Idiopathic pulmonary fibrosis;IgA nephropathy;IgM nephropathy;IIIrd nerve
paralysis;IIIrd nerve paresis;Iliac artery embolism;Immune thrombocytopenia;Immunemediated adverse reaction;Immune-mediated cholangitis;Immune-mediated
cholestasis;Immune-mediated cytopenia;Immune-mediated encephalitis;Immune-mediated
encephalopathy;Immune-mediated endocrinopathy;Immune-mediated enterocolitis;Immunemediated gastritis;Immune-mediated hepatic disorder;Immune-mediated hepatitis;Immunemediated hyperthyroidism;Immune-mediated hypothyroidism;Immune-mediated
myocarditis;Immune-mediated myositis;Immune-mediated nephritis;Immune-mediated
neuropathy;Immune-mediated pancreatitis;Immune-mediated pneumonitis;Immune-mediated
renal disorder;Immune-mediated thyroiditis;Immune-mediated uveitis;Immunoglobulin G4
related disease;Immunoglobulins abnormal;Implant site thrombosis;Inclusion body
myositis;Infantile genetic agranulocytosis;Infantile spasms;Infected vasculitis;Infective
thrombosis;Inflammation;Inflammatory bowel disease;Infusion site thrombosis;Infusion site
vasculitis;Injection site thrombosis;Injection site urticaria;Injection site vasculitis;Instillation
site thrombosis;Insulin autoimmune syndrome;Interstitial granulomatous
dermatitis;Interstitial lung disease;Intracardiac mass;Intracardiac thrombus;Intracranial
pressure increased;Intrapericardial thrombosis;Intrinsic factor antibody abnormal;Intrinsic
factor antibody positive;IPEX syndrome;Irregular breathing;IRVAN syndrome;IVth nerve
paralysis;IVth nerve paresis;JC polyomavirus test positive;JC virus CSF test positive;Jeavons
syndrome;Jugular vein embolism;Jugular vein thrombosis;Juvenile idiopathic
arthritis;Juvenile myoclonic epilepsy;Juvenile polymyositis;Juvenile psoriatic
arthritis;Juvenile spondyloarthritis;Kaposi sarcoma inflammatory cytokine
syndrome;Kawasaki's disease;Kayser-Fleischer ring;Keratoderma blenorrhagica;Ketosisprone diabetes mellitus;Kounis syndrome;Lafora's myoclonic epilepsy;Lambl's
excrescences;Laryngeal dyspnoea;Laryngeal oedema;Laryngeal rheumatoid
arthritis;Laryngospasm;Laryngotracheal oedema;Latent autoimmune diabetes in adults;LE
cells present;Lemierre syndrome;Lennox-Gastaut syndrome;Leucine aminopeptidase
increased;Leukoencephalomyelitis;Leukoencephalopathy;Leukopenia;Leukopenia
neonatal;Lewis-Sumner syndrome;Lhermitte's sign;Lichen planopilaris;Lichen planus;Lichen
sclerosus;Limbic encephalitis;Linear IgA disease;Lip oedema;Lip swelling;Liver function
test abnormal;Liver function test decreased;Liver function test increased;Liver
induration;Liver injury;Liver iron concentration abnormal;Liver iron concentration

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 6
increased;Liver opacity;Liver palpable;Liver sarcoidosis;Liver scan abnormal;Liver
tenderness;Low birth weight baby;Lower respiratory tract herpes infection;Lower respiratory
tract infection;Lower respiratory tract infection viral;Lung abscess;Lupoid hepatic
cirrhosis;Lupus cystitis;Lupus encephalitis;Lupus endocarditis;Lupus enteritis;Lupus
hepatitis;Lupus myocarditis;Lupus myositis;Lupus nephritis;Lupus pancreatitis;Lupus
pleurisy;Lupus pneumonitis;Lupus vasculitis;Lupus-like syndrome;Lymphocytic
hypophysitis;Lymphocytopenia neonatal;Lymphopenia;MAGIC syndrome;Magnetic
resonance imaging liver abnormal;Magnetic resonance proton density fat fraction
measurement;Mahler sign;Manufacturing laboratory analytical testing issue;Manufacturing
materials issue;Manufacturing production issue;Marburg's variant multiple
sclerosis;Marchiafava-Bignami disease;Marine Lenhart syndrome;Mastocytic
enterocolitis;Maternal exposure during pregnancy;Medical device site thrombosis;Medical
device site vasculitis;MELAS syndrome;Meningitis;Meningitis aseptic;Meningitis
herpes;Meningoencephalitis herpes simplex neonatal;Meningoencephalitis
herpetic;Meningomyelitis herpes;MERS-CoV test;MERS-CoV test negative;MERS-CoV test
positive;Mesangioproliferative glomerulonephritis;Mesenteric artery embolism;Mesenteric
artery thrombosis;Mesenteric vein thrombosis;Metapneumovirus infection;Metastatic
cutaneous Crohn's disease;Metastatic pulmonary
embolism;Microangiopathy;Microembolism;Microscopic polyangiitis;Middle East
respiratory syndrome;Migraine-triggered seizure;Miliary pneumonia;Miller Fisher
syndrome;Mitochondrial aspartate aminotransferase increased;Mixed connective tissue
disease;Model for end stage liver disease score abnormal;Model for end stage liver disease
score increased;Molar ratio of total branched-chain amino acid to tyrosine;Molybdenum
cofactor deficiency;Monocytopenia;Mononeuritis;Mononeuropathy
multiplex;Morphoea;Morvan syndrome;Mouth swelling;Moyamoya disease;Multifocal
motor neuropathy;Multiple organ dysfunction syndrome;Multiple sclerosis;Multiple sclerosis
relapse;Multiple sclerosis relapse prophylaxis;Multiple subpial transection;Multisystem
inflammatory syndrome in children;Muscular sarcoidosis;Myasthenia gravis;Myasthenia
gravis crisis;Myasthenia gravis neonatal;Myasthenic syndrome;Myelitis;Myelitis
transverse;Myocardial infarction;Myocarditis;Myocarditis post infection;Myoclonic
epilepsy;Myoclonic epilepsy and ragged-red fibres;Myokymia;Myositis;Narcolepsy;Nasal
herpes;Nasal obstruction;Necrotising herpetic retinopathy;Neonatal Crohn's disease;Neonatal
epileptic seizure;Neonatal lupus erythematosus;Neonatal mucocutaneous herpes
simplex;Neonatal pneumonia;Neonatal seizure;Nephritis;Nephrogenic systemic
fibrosis;Neuralgic amyotrophy;Neuritis;Neuritis cranial;Neuromyelitis optica pseudo
relapse;Neuromyelitis optica spectrum disorder;Neuromyotonia;Neuronal
neuropathy;Neuropathy peripheral;Neuropathy, ataxia, retinitis pigmentosa
syndrome;Neuropsychiatric lupus;Neurosarcoidosis;Neutropenia;Neutropenia
neonatal;Neutropenic colitis;Neutropenic infection;Neutropenic sepsis;Nodular rash;Nodular
vasculitis;Noninfectious myelitis;Noninfective encephalitis;Noninfective
encephalomyelitis;Noninfective oophoritis;Obstetrical pulmonary embolism;Occupational
exposure to communicable disease;Occupational exposure to SARS-CoV-2;Ocular
hyperaemia;Ocular myasthenia;Ocular pemphigoid;Ocular sarcoidosis;Ocular
vasculitis;Oculofacial paralysis;Oedema;Oedema blister;Oedema due to hepatic
disease;Oedema mouth;Oesophageal achalasia;Ophthalmic artery thrombosis;Ophthalmic
herpes simplex;Ophthalmic herpes zoster;Ophthalmic vein thrombosis;Optic neuritis;Optic

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 7
neuropathy;Optic perineuritis;Oral herpes;Oral lichen planus;Oropharyngeal
oedema;Oropharyngeal spasm;Oropharyngeal swelling;Osmotic demyelination
syndrome;Ovarian vein thrombosis;Overlap syndrome;Paediatric autoimmune
neuropsychiatric disorders associated with streptococcal infection;Paget-Schroetter
syndrome;Palindromic rheumatism;Palisaded neutrophilic granulomatous
dermatitis;Palmoplantar keratoderma;Palpable
purpura;Pancreatitis;Panencephalitis;Papillophlebitis;Paracancerous pneumonia;Paradoxical
embolism;Parainfluenzae viral laryngotracheobronchitis;Paraneoplastic
dermatomyositis;Paraneoplastic pemphigus;Paraneoplastic thrombosis;Paresis cranial
nerve;Parietal cell antibody positive;Paroxysmal nocturnal haemoglobinuria;Partial
seizures;Partial seizures with secondary generalisation;Patient isolation;Pelvic venous
thrombosis;Pemphigoid;Pemphigus;Penile vein thrombosis;Pericarditis;Pericarditis
lupus;Perihepatic discomfort;Periorbital oedema;Periorbital swelling;Peripheral artery
thrombosis;Peripheral embolism;Peripheral ischaemia;Peripheral vein thrombus
extension;Periportal oedema;Peritoneal fluid protein abnormal;Peritoneal fluid protein
decreased;Peritoneal fluid protein increased;Peritonitis lupus;Pernicious anaemia;Petit mal
epilepsy;Pharyngeal oedema;Pharyngeal swelling;Pityriasis lichenoides et varioliformis
acuta;Placenta praevia;Pleuroparenchymal fibroelastosis;Pneumobilia;Pneumonia;Pneumonia
adenoviral;Pneumonia cytomegaloviral;Pneumonia herpes viral;Pneumonia
influenzal;Pneumonia measles;Pneumonia mycoplasmal;Pneumonia necrotising;Pneumonia
parainfluenzae viral;Pneumonia respiratory syncytial viral;Pneumonia viral;POEMS
syndrome;Polyarteritis nodosa;Polyarthritis;Polychondritis;Polyglandular autoimmune
syndrome type I;Polyglandular autoimmune syndrome type II;Polyglandular autoimmune
syndrome type III;Polyglandular disorder;Polymicrogyria;Polymyalgia
rheumatica;Polymyositis;Polyneuropathy;Polyneuropathy idiopathic progressive;Portal
pyaemia;Portal vein embolism;Portal vein flow decreased;Portal vein pressure
increased;Portal vein thrombosis;Portosplenomesenteric venous thrombosis;Post procedural
hypotension;Post procedural pneumonia;Post procedural pulmonary embolism;Post stroke
epilepsy;Post stroke seizure;Post thrombotic retinopathy;Post thrombotic syndrome;Post viral
fatigue syndrome;Postictal headache;Postictal paralysis;Postictal psychosis;Postictal
state;Postoperative respiratory distress;Postoperative respiratory failure;Postoperative
thrombosis;Postpartum thrombosis;Postpartum venous thrombosis;Postpericardiotomy
syndrome;Post-traumatic epilepsy;Postural orthostatic tachycardia syndrome;Precerebral
artery thrombosis;Pre-eclampsia;Preictal state;Premature labour;Premature
menopause;Primary amyloidosis;Primary biliary cholangitis;Primary progressive multiple
sclerosis;Procedural shock;Proctitis herpes;Proctitis ulcerative;Product availability
issue;Product distribution issue;Product supply issue;Progressive facial
hemiatrophy;Progressive multifocal leukoencephalopathy;Progressive multiple
sclerosis;Progressive relapsing multiple sclerosis;Prosthetic cardiac valve
thrombosis;Pruritus;Pruritus allergic;Pseudovasculitis;Psoriasis;Psoriatic
arthropathy;Pulmonary amyloidosis;Pulmonary artery thrombosis;Pulmonary
embolism;Pulmonary fibrosis;Pulmonary haemorrhage;Pulmonary microemboli;Pulmonary
oil microembolism;Pulmonary renal syndrome;Pulmonary sarcoidosis;Pulmonary
sepsis;Pulmonary thrombosis;Pulmonary tumour thrombotic microangiopathy;Pulmonary
vasculitis;Pulmonary veno-occlusive disease;Pulmonary venous thrombosis;Pyoderma
gangrenosum;Pyostomatitis vegetans;Pyrexia;Quarantine;Radiation leukopenia;Radiculitis

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 8
brachial;Radiologically isolated syndrome;Rash;Rash erythematous;Rash pruritic;Rasmussen
encephalitis;Raynaud's phenomenon;Reactive capillary endothelial proliferation;Relapsing
multiple sclerosis;Relapsing-remitting multiple sclerosis;Renal amyloidosis;Renal
arteritis;Renal artery thrombosis;Renal embolism;Renal failure;Renal vascular
thrombosis;Renal vasculitis;Renal vein embolism;Renal vein thrombosis;Respiratory
arrest;Respiratory disorder;Respiratory distress;Respiratory failure;Respiratory
paralysis;Respiratory syncytial virus bronchiolitis;Respiratory syncytial virus
bronchitis;Retinal artery embolism;Retinal artery occlusion;Retinal artery thrombosis;Retinal
vascular thrombosis;Retinal vasculitis;Retinal vein occlusion;Retinal vein thrombosis;Retinol
binding protein decreased;Retinopathy;Retrograde portal vein flow;Retroperitoneal
fibrosis;Reversible airways obstruction;Reynold's syndrome;Rheumatic brain
disease;Rheumatic disorder;Rheumatoid arthritis;Rheumatoid factor increased;Rheumatoid
factor positive;Rheumatoid factor quantitative increased;Rheumatoid lung;Rheumatoid
neutrophilic dermatosis;Rheumatoid nodule;Rheumatoid nodule removal;Rheumatoid
scleritis;Rheumatoid vasculitis;Saccadic eye movement;SAPHO
syndrome;Sarcoidosis;SARS-CoV-1 test;SARS-CoV-1 test negative;SARS-CoV-1 test
positive;SARS-CoV-2 antibody test;SARS-CoV-2 antibody test negative;SARS-CoV-2
antibody test positive;SARS-CoV-2 carrier;SARS-CoV-2 sepsis;SARS-CoV-2 test;SARSCoV-2 test false negative;SARS-CoV-2 test false positive;SARS-CoV-2 test negative;SARSCoV-2 test positive;SARS-CoV-2 viraemia;Satoyoshi
syndrome;Schizencephaly;Scleritis;Sclerodactylia;Scleroderma;Scleroderma associated
digital ulcer;Scleroderma renal crisis;Scleroderma-like reaction;Secondary
amyloidosis;Secondary cerebellar degeneration;Secondary progressive multiple
sclerosis;Segmented hyalinising vasculitis;Seizure;Seizure anoxic;Seizure cluster;Seizure
like phenomena;Seizure prophylaxis;Sensation of foreign body;Septic embolus;Septic
pulmonary embolism;Severe acute respiratory syndrome;Severe myoclonic epilepsy of
infancy;Shock;Shock symptom;Shrinking lung syndrome;Shunt thrombosis;Silent
thyroiditis;Simple partial seizures;Sjogren's syndrome;Skin swelling;SLE arthritis;Smooth
muscle antibody positive;Sneezing;Spinal artery embolism;Spinal artery thrombosis;Splenic
artery thrombosis;Splenic embolism;Splenic thrombosis;Splenic vein
thrombosis;Spondylitis;Spondyloarthropathy;Spontaneous heparin-induced
thrombocytopenia syndrome;Status epilepticus;Stevens-Johnson syndrome;Stiff leg
syndrome;Stiff person syndrome;Stillbirth;Still's disease;Stoma site thrombosis;Stoma site
vasculitis;Stress cardiomyopathy;Stridor;Subacute cutaneous lupus erythematosus;Subacute
endocarditis;Subacute inflammatory demyelinating polyneuropathy;Subclavian artery
embolism;Subclavian artery thrombosis;Subclavian vein thrombosis;Sudden unexplained
death in epilepsy;Superior sagittal sinus thrombosis;Susac's syndrome;Suspected COVID19;Swelling;Swelling face;Swelling of eyelid;Swollen tongue;Sympathetic
ophthalmia;Systemic lupus erythematosus;Systemic lupus erythematosus disease activity
index abnormal;Systemic lupus erythematosus disease activity index decreased;Systemic
lupus erythematosus disease activity index increased;Systemic lupus erythematosus
rash;Systemic scleroderma;Systemic sclerosis
pulmonary;Tachycardia;Tachypnoea;Takayasu's arteritis;Temporal lobe epilepsy;Terminal
ileitis;Testicular autoimmunity;Throat tightness;Thromboangiitis
obliterans;Thrombocytopenia;Thrombocytopenic
purpura;Thrombophlebitis;Thrombophlebitis migrans;Thrombophlebitis

BNT162b2
5.3.6 Cumulative Analysis of Post-authorization Adverse Event Reports
CONFIDENTIAL
Page 9
neonatal;Thrombophlebitis septic;Thrombophlebitis superficial;Thromboplastin antibody
positive;Thrombosis;Thrombosis corpora cavernosa;Thrombosis in device;Thrombosis
mesenteric vessel;Thrombotic cerebral infarction;Thrombotic microangiopathy;Thrombotic
stroke;Thrombotic thrombocytopenic purpura;Thyroid disorder;Thyroid stimulating
immunoglobulin increased;Thyroiditis;Tongue amyloidosis;Tongue biting;Tongue
oedema;Tonic clonic movements;Tonic convulsion;Tonic posturing;Topectomy;Total bile
acids increased;Toxic epidermal necrolysis;Toxic leukoencephalopathy;Toxic oil
syndrome;Tracheal obstruction;Tracheal oedema;Tracheobronchitis;Tracheobronchitis
mycoplasmal;Tracheobronchitis viral;Transaminases abnormal;Transaminases
increased;Transfusion-related alloimmune neutropenia;Transient epileptic
amnesia;Transverse sinus thrombosis;Trigeminal nerve paresis;Trigeminal
neuralgia;Trigeminal palsy;Truncus coeliacus thrombosis;Tuberous sclerosis
complex;Tubulointerstitial nephritis and uveitis syndrome;Tumefactive multiple
sclerosis;Tumour embolism;Tumour thrombosis;Type 1 diabetes mellitus;Type I
hypersensitivity;Type III immune complex mediated reaction;Uhthoff's
phenomenon;Ulcerative keratitis;Ultrasound liver abnormal;Umbilical cord
thrombosis;Uncinate fits;Undifferentiated connective tissue disease;Upper airway
obstruction;Urine bilirubin increased;Urobilinogen urine decreased;Urobilinogen urine
increased;Urticaria;Urticaria papular;Urticarial vasculitis;Uterine
rupture;Uveitis;Vaccination site thrombosis;Vaccination site vasculitis;Vagus nerve
paralysis;Varicella;Varicella keratitis;Varicella post vaccine;Varicella zoster
gastritis;Varicella zoster oesophagitis;Varicella zoster pneumonia;Varicella zoster
sepsis;Varicella zoster virus infection;Vasa praevia;Vascular graft thrombosis;Vascular
pseudoaneurysm thrombosis;Vascular purpura;Vascular stent thrombosis;Vasculitic
rash;Vasculitic ulcer;Vasculitis;Vasculitis gastrointestinal;Vasculitis necrotising;Vena cava
embolism;Vena cava thrombosis;Venous intravasation;Venous recanalisation;Venous
thrombosis;Venous thrombosis in pregnancy;Venous thrombosis limb;Venous thrombosis
neonatal;Vertebral artery thrombosis;Vessel puncture site thrombosis;Visceral venous
thrombosis;VIth nerve paralysis;VIth nerve paresis;Vitiligo;Vocal cord paralysis;Vocal cord
paresis;Vogt-Koyanagi-Harada disease;Warm type haemolytic anaemia;Wheezing;White
nipple sign;XIth nerve paralysis;X-ray hepatobiliary abnormal;Young's syndrome;Zika virus
associated Guillain Barre syndrome.

↑

ファイザーが米国FDAに提出した「治験データ」の内容が、それだ。

mRNAワクチン接種が大好きで2回どころか「3回目」も接種しました、と回数自慢さえしている「そこの貴方」

あなたは、上記の1000を超える複雑な病気を惹起する「毒物」を注射したんですよ、自らの意思でね。

それがどれほど「愚か」なことか？まだ、理解できないのですか？

一体、これまで「どのような」人生を歩んで来たのでしょうか？
8：市民の会 :
2022/03/30 (Wed) 13:51:10
host:*.openmobile.ne.jp: 　
9：市民の会 :
2022/03/30 (Wed) 13:56:26
host:*.openmobile.ne.jp: 心臓病や、脳梗塞の怖れある持病持ちの人間が「わざわざ」自らすすんで、血栓毒を生成するワクチン（毒珍だ）を接種した。

一度目は「悲劇」として、しかし二度目以降は「喜劇」として、、じゃないか

愚かなことをしたものだ。
10：市民の会 :
2022/03/30 (Wed) 13:59:57
host:*.openmobile.ne.jp: 日本民族の「遺伝子」は、消えるんじゃないか？
11：市民の会 :
2022/03/30 (Wed) 14:04:19
host:*.openmobile.ne.jp: 　
12：市民の会 :
2022/03/30 (Wed) 14:08:52
host:*.openmobile.ne.jp: